查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1776193

S状结肠镜子的全球市场:洞察，竞争情形，市场预测:2032年

Sigmoidoscopes - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计在2025年至2032年的预测期内，乙状结肠镜市场将以5.57%的复合年增长率扩张。由于大肠直肠癌、发炎性肠道疾病 (IBD)、憩室炎和息肉等慢性疾病的增多、老龄人口的增长、人们对胃肠道疾病早期诊断意识的增强以及向微创手术的日益转变，乙状结肠镜市场正在经历显着增长，所有这些因素预计都将在2025年至2032年的预测期内对乙状镜的需求增长。

乙状结肠镜市场动态：

根据全球癌症观察组织 (Global Cancer Observatory) 2024 年的数据，大肠直肠癌在亚洲占50.2%，在欧洲占27.9%，非洲为3.7%。根据同一数据来源显示，2022年全球将新增约139万例大肠癌病例，预计2045年将达到329万例。随着早期发现和诊断需求的不断增长，日益加重的全球负担显着推动了对乙状结肠镜的需求。

乙状结肠镜在结直肠癌的早期发现中发挥关键作用。它们使医生能够直接观察直肠和乙状结肠，而癌症和息肉在这些部位最为常见。因此，乙状结肠镜正成为预防性医疗保健和常规诊断方案的重要组成部分。

此外，世界胃肠病学组织（2024年）报告称，49%的女性和36.6%的男性符合至少一种功能性胃肠病（FGID）的诊断标准。最常见的疾病是功能性便秘（11.7%）、功能性消化不良（7.2%）、直肠疼痛（5.9%）、功能性腹泻（4.7%）和肠躁症 (IBS)（4.1%）。由于许多此类疾病需要直接检查直肠和乙状结肠才能进行准确诊断和製定治疗计划，因此医院、诊所和胃肠病中心对乙状结肠镜检查的采用正在迅速增加。

此外，随着全球癌症发生率预计会增加，医疗保健系统正在增加对先进诊断工具和技术的投资。早期发现和预防保健变得越来越重要。例如，2024 年 1 月，奥林巴斯株式会社以 3.7 亿美元收购了泰熊医疗株式会社。此次策略性收购旨在扩大奥林巴斯的胃肠治疗产品组合，并增强其在胃肠疾病诊断和治疗设备方面的能力。

此外，根据世界卫生组织 (WHO) (2024) 的预测，到 2050 年，全球约 80% 的老年人口将居住在中低收入国家。由于老年人更容易患上需要早期诊断的胃肠道疾病，预计对乙状结肠镜等便捷诊断解决方案的需求将大幅增长，尤其是在新兴市场。

因此，预计在 2025 年至 2032 年的预测期内，结直肠癌发病率上升、功能性胃肠道疾病 (FGID) 患病率上升、老年人口增长以及医疗保健进步等因素将推动乙状结肠镜市场强劲增长。

然而，由于替代诊断方法的可用性、乙状结肠镜检查相关的併发症和感染的潜在风险以及患者不适，乙状结肠镜可能面临某些限制，这可能会阻碍其广泛应用。

乙状结肠镜市场区隔分析：

乙状结肠镜市场分析，按产品类型（硬性、柔性）、用途（一次性、可重复使用）、最终用户（医院和诊所、门诊手术中心、其他）和地区（北美、欧洲、亚太地区、其他）进行

按产品类型划分，柔性乙状结肠镜预计将在2024年占据相当大的收入占有率。这是因为它们相比硬性型号具有许多优势。柔性乙状结肠镜的日益普及，极大地推动了整个乙状结肠镜市场的发展，这主要得益于其临床实用性、患者舒适度的提升以及技术的不断发展。与硬性乙状结肠镜不同，柔性乙状结肠镜可以更深入地观察乙状结肠，并提高操作灵活性，使医生能够更准确地发现异常。

此外，这些仪器更容易取得且经济高效，因为它们疼痛程度较低，通常无需镇静，并且可以在门诊进行。例如，全球内视镜领域的领导者奥林巴斯公司在其 EVIS EXERA III 平台中提供先进的柔性乙状结肠镜，该平台以其高清影像和窄带成像 (NBI) 技术而闻名，可增强黏膜的可视化，从而提高结肠息肉和早期癌性病变的检出率。宾得医疗生产的柔性视讯乙状结肠镜（例如 EC-3490LK）采用人体工学设计和 HD+ 视觉化技术，广泛应用于胃肠病房和诊所。这些技术创新使得柔性乙状结肠镜检查在常规大肠筛检中更具吸引力，尤其是在医疗保健系统日益重视大肠癌预防保健的当下。

此外，像 Ambu A/S 这样的公司已经推出了一次性柔性乙状结肠镜，例如 Ambu® aScope Gastro，它在提供便利性和无菌性的同时，也解决了感染控制问题。柔性乙状结肠镜被纳入国家癌症筛检项目，例如英国国家医疗服务体系 (NHS) 的肠镜筛检项目，这进一步加速了其临床应用。总体而言，对柔性乙状结肠镜日益增长的依赖，加上光学清晰度、数位成像和一次性使用形式的改进，正在推动全球乙状结肠镜市场的成长。

预计北美将主导整个乙状结肠镜市场：

在所有地区中，预计北美将在2024年主导乙状结肠镜市场。这可以归因于多种因素，包括技术进步、监管部门的批准、主要参与者的庞大市场占有率、对医疗基础设施的持续投资，以及创新产品开髮带来的结直肠癌患者数量的增加，预计这些因素将在2025年至2032年的预测期内推动乙状结肠镜市场的发展。

根据国际癌症研究机构（2024年）的数据，北美将新增约18.4万例大肠直肠癌病例，预计到2050年这一数字将增至25万例。随着大肠直肠癌发生率的持续上升，早期发现和有效筛检方法的需求变得越来越重要。乙状结肠镜检查是检查直肠和乙状结肠的重要诊断程序，在检测和监测大肠直肠异常方面发挥着至关重要的作用。随着大肠直肠癌负担的增加，对乙状结肠镜检查的需求也日益增长，医疗保健提供者也越来越依赖这项工具进行及时诊断和介入。

此外，美国胃肠病学会 (AGA) 报告指出（2024 年），约有 6,000 万至 7,000 万美国人患有胃肠道 (GI) 疾病。发炎性肠道疾病 (IBD)、溃疡性结肠炎、直肠炎、憩室病和结肠息肉等疾病的盛行率不断上升，进一步推动了对乙状结肠镜的需求。这些疾病通常会影响下消化道，尤其是直肠和乙状结肠，使用乙状结肠镜进行观察效果最佳。例如，溃疡性结肠炎患者通常需要定期进行乙状结肠镜检查，以监测黏膜发炎并评估治疗效果。

此外，由于强生服务公司、奥林巴斯公司和百特等主要公司拥有强大的分销网络，乙状结肠镜在该地区广泛普及。此外，优惠的报销政策进一步推动了乙状结肠镜的普及，创造了巨大的市场成长机会。

总而言之，大肠直肠癌和消化系统疾病盛行率的上升，加上技术的可及性、强大的市场参与者和支持性的医疗政策，预计将推动北美乙状结肠镜市场的显着增长。

乙状结肠镜市场的主要参与者

乙状结肠镜市场的主要参与者包括奥林巴斯公司、百特公司、阿德勒仪器公司、Bioseal公司、Rocket Medical plc.、康美公司、强生服务公司、美敦力公司、Ambu A/S公司、SCHOLLY FIBEROPTIC GMBH公司、SonoScape Medical Corp.、Interscope公司和Ovesco Endospycopy 公司。

乙状结肠镜市场的最新发展：

  • 2024年2月，富士软片印度公司在印度推出了突破性的ALOKA ARIETTA 850诊断超音波系统。这款高科技超音波系统旨在提高该地区胃肠道疾病的诊断准确性和影像清晰度。
  • 2023年5月，奥林巴斯宣布EVIS X1内视镜系统及两款相容的胃肠内视镜获得FDA批准。 GIF-1100胃肠内视镜适用于上消化道，包括食道、胃和十二指肠；CF-HQ1100DL/I结肠内视镜适用于下消化道，包括肛门、直肠、乙状结肠、结肠和迴盲瓣。

乙状结肠镜市场研究报告重点

  • 乙状结肠镜目前市场规模分析（2024 年）及八年市场预测（2025-2032 年）
  • 过去三年主要产品/服务开发、併购、合作及合资企业
  • 主导乙状结肠镜市场的主要公司
  • 乙状结肠镜市场竞争对手面临的各种机会
  • 哪些细分市场将在 2024 年名列前茅？这些细分市场在 2032 年的表现
  • 目前乙状结肠镜市场情势下的主要地区和国家
  • 未来公司应关注乙状结肠镜市场成长机会的地区和国家

乙状结肠镜市场常见问题

1.乙状结肠镜

  • 乙状结肠镜是一种用于检查直肠和乙状结肠（大肠下部）的医疗器材。它常用于诊断和治疗，例如识别异常（息肉、发炎和癌症）、监测发炎性肠道疾病以及进行活检。

2. 乙状结肠镜市场

  • 预计在 2025 年至 2032 年的预测期内，乙状结肠镜市场将以 5.57% 的复合年增长率成长。

3.推动乙状结肠镜市场发展的因素

  • 乙状结肠镜市场的主要参与者包括奥林巴斯公司、百特公司、阿德勒仪器公司、Bioseal公司、Rocket Medical plc.、ConMed公司、强生服务公司、美敦力公司、Ambu A/S公司、SCHOLLY FIBEROPTIC GMBH公司、SonoScape Medical Corp.、Interscope公司和Ovesco Endospycopy 公司。

5.乙状结肠镜市占率最大的地区

  • 在所有地区中，预计北美将在2024年占据乙状结肠镜市场的主导地位。这可以归因于多种因素，包括技术进步、监管部门的批准、大型公司的庞大市场占有率、对医疗基础设施的持续投资，以及创新产品开髮带来的结直肠癌患者数量的增加，预计这些因素将在2025年至2032年的预测期内推动乙状结肠镜市场的发展。

目录

第1章 S状结肠镜市场报告的简介

第2章 S状结肠镜子市场摘要整理

第3章 竞争情形

第4章 法规分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第5章 S状结肠镜子市场主要原因分析

  • 乙状结肠镜市场推动因素
    • 大肠直肠癌和胃肠道疾病发生率上升
    • 老化人口成长
    • 胃肠道疾病早期诊断意识增强
  • 乙状结肠镜市场限制与挑战
    • 替代方案的可用性
    • 与这些装置相关的併发症和感染风险
  • 乙状结肠镜的市场机遇
    • 乙状结肠镜与远距医疗平台的整合以及AI辅助诊断

第6章 乙状结肠镜市场波特的五力分析

第7章 S状结肠镜子市场评估

  • 各产品类型
    • 硬式
    • 软性
  • 按实用性
    • 抛弃式
    • 再利用型
  • 各终端用户
    • 医院和诊疗所
    • 门诊病人手术中心
    • 其他
  • 地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第8章 S状结肠镜子市场企业与产品简介

  • Olympus Corporation
  • Baxter
  • Adler Instrument Company
  • Bioseal Inc.
  • Rocket Medical plc.
  • ConMed Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic
  • Ambu A/S
  • SCHOLLY FIBEROPTIC GMBH
  • SonoScape Medical Corp.
  • Interscope, Inc.
  • Ovesco Endoscopy AG

第9章 KOL的见解

第10章 计划方法

第11章 关于DelveInsight

第12章 免责声明和咨询方式

Product Code: DIMDCL0203

Sigmoidoscopes Market by Product Type (Rigid and Flexible), Usability (Disposable and Reusable), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2032 owing to the increasing instances of chronic conditions and rising awareness about early diagnosis of gastro-intestinal disorders globally.

The sigmoidoscopes market is estimated to grow at a CAGR of 5.57% during the forecast period from 2025 to 2032. The sigmoidoscopes market is growing significantly due to the increasing instances of chronic conditions such colorectal cancer, inflammatory bowel diseases (IBD), diverticulitis, and polyps, growing geriatric population, rising awareness about early diagnosis of gastro-intestinal disorders, increasing shift towards minimally invasive procedures, and others that are expected to escalate the demand for sigmoidoscopes during the forecast period from 2025 to 2032.

Sigmoidoscopes Market Dynamics:

According to the Global Cancer Observatory (2024), colorectal cancer accounted for 50.2% of cancer cases in Asia, 27.9% in Europe, and 3.7% in Africa. The same source also reported that in 2022, there were approximately 1.39 million cases of colorectal cancer worldwide, a number projected to reach 3.29 million by 2045. This rising global burden is significantly driving the demand for sigmoidoscopes, as the need for early detection and diagnosis continues to grow.

Sigmoidoscopy plays a critical role in the early identification of colorectal cancer. It allows physicians to directly visualize the rectum and sigmoid colon, which are common sites for cancer and polyps. As a result, sigmoidoscopes are increasingly becoming a key component of preventive healthcare and routine diagnostic protocols.

In addition, the World Gastroenterology Organization (2024) reported that 49% of females and 36.6% of males met the criteria for at least one functional gastrointestinal disorder (FGID). The most prevalent disorders included functional constipation (11.7%), functional dyspepsia (7.2%), proctalgia fugax (5.9%), functional diarrhea (4.7%), and irritable bowel syndrome (IBS) (4.1%). Since many of these conditions require direct examination of the rectum and sigmoid colon for accurate diagnosis and treatment planning, the adoption of sigmoidoscopy procedures has surged across hospitals, clinics, and gastroenterology centers.

Furthermore, with the expected rise in global cancer incidence, healthcare systems are increasingly investing in advanced diagnostic tools and technologies. A greater emphasis is being placed on early detection and preventive care. For instance, in January 2024, Olympus Corporation acquired Taewoong Medical Co., Ltd. for USD 370 million. This strategic acquisition is aimed at expanding Olympus's gastrointestinal endotherapy portfolio and strengthening its capabilities in both diagnostic and therapeutic devices for GI disorders.

Moreover, according to the World Health Organization (2024), by 2050, around 80% of the global elderly population will reside in low- and middle-income countries. As older adults are more prone to gastrointestinal issues that require early diagnosis, the demand for accessible diagnostic solutions such as sigmoidoscopes is expected to increase significantly, especially in emerging markets.

Therefore, the combination of rising colorectal cancer prevalence, increasing incidence of FGIDs, growing geriatric population, and healthcare advancements is anticipated to drive robust growth in the sigmoidoscope market during the forecast period from 2025 to 2032.

However, the market may face certain limitations due to the availability of alternative diagnostic methods, potential risks of complications and infections associated with sigmoidoscopy, and patient discomfort, which could hinder its widespread adoption.

Sigmoidoscopes Market Segment Analysis:

Sigmoidoscopes Market by Product Type (Rigid and Flexible), Usability (Disposable and Reusable), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of sigmoidoscopes, the flexible category is expected to have a significant revenue share in the year 2024. This is due to the numerous advantages over rigid models. The growing adoption of flexible sigmoidoscopes is significantly boosting the overall market for sigmoidoscopes, largely due to their enhanced clinical utility, patient comfort, and evolving technology. Unlike rigid sigmoidoscopes, flexible variants allow for deeper navigation of the sigmoid colon and better maneuverability, enabling physicians to detect abnormalities with greater accuracy.

Additionally, these devices are less painful, often do not require sedation, and allow for procedures to be performed in outpatient settings, making them more accessible and cost-effective. For instance, Olympus Corporation, a global leader in endoscopy, offers advanced flexible sigmoidoscopes that are part of its EVIS EXERA III platform, known for high-definition imaging and Narrow Band Imaging (NBI) technology that enhances mucosal visualization. This allows for improved detection of colorectal polyps and early-stage cancer lesions. Another notable example is Pentax Medical, which manufactures flexible video sigmoidoscopes such as the EC-3490LK, featuring ergonomic design and HD+ visualization, widely used in GI units and clinics. These innovations have made flexible sigmoidoscopy more appealing for routine colorectal screenings, especially as health systems emphasize preventive care for colorectal cancer.

Additionally, companies like Ambu A/S have introduced single-use flexible sigmoidoscopes, such as the Ambu(R) aScope Gastro, addressing infection control concerns while offering convenience and sterility. The integration of flexible sigmoidoscopy into national cancer screening programs such as the NHS Bowel Scope Screening in the UK has further accelerated its clinical adoption. Overall, the increasing reliance on flexible sigmoidoscopes, combined with improvements in optical clarity, digital imaging, and single-use formats, is playing a pivotal role in driving the growth of the sigmoidoscope market globally.

North America is expected to dominate the overall sigmoidoscopes market:

Among all the regions, North America is expected to dominate the sigmoidoscopes market in the year 2024. This can be attributed to several factors, such as rising colorectal cancer cases, enhanced by technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure, and innovative product developments that are expected to drive the market for sigmoidoscopes during the forecast period from 2025 to 2032.

According to data from the International Agency for Research on Cancer (2024), the number of new colorectal cancer cases in North America was approximately 184,000, and this figure is projected to rise to 250,000 by 2050. As the incidence of colorectal cancer continues to increase, the need for early detection and effective screening methods becomes more critical. Sigmoidoscopy, a key diagnostic procedure for examining the rectum and sigmoid colon, plays a vital role in identifying and monitoring colorectal abnormalities. With the rising burden of colorectal cancer, the demand for sigmoidoscopes is growing, as healthcare providers increasingly rely on this tool for timely diagnosis and intervention.

Additionally, the American Gastroenterological Association (2024) reported that approximately 60-70 million Americans are affected by gastrointestinal (GI) diseases. The increasing prevalence of conditions such as inflammatory bowel disease (IBD), ulcerative colitis, proctitis, diverticulosis, and colorectal polyps is further driving the demand for sigmoidoscopes. These disorders commonly affect the lower gastrointestinal tract, specifically the rectum and sigmoid colon areas, best visualized using a sigmoidoscope. For instance, patients with ulcerative colitis often require regular sigmoidoscopic evaluations to monitor mucosal inflammation and assess treatment response.

Moreover, the presence of key industry players such as Johnson & Johnson Services, Inc., Olympus Corporation, and Baxter, backed by robust distribution networks, ensures wide accessibility and availability of sigmoidoscopes across the region. In addition, favorable reimbursement policies further support adoption, creating significant market growth opportunities.

In conclusion, the rising prevalence of colorectal cancer and GI diseases, combined with technological accessibility, strong market players, and supportive healthcare policies, are expected to foster substantial growth for the sigmoidoscope market in North America.

Sigmoidoscopes Market Key Players:

Some of the key market players operating in the sigmoidoscopes market include Olympus Corporation, Baxter, Adler Instrument Company, Bioseal Inc., Rocket Medical plc., ConMed Corporation, Johnson & Johnson Services, Inc., Medtronic, Ambu A/S, SCHOLLY FIBEROPTIC GMBH, SonoScape Medical Corp., Interscope, Inc., Ovesco Endoscopy AG, and others.

Recent Developmental Activities in the Sigmoidoscopes Market:

  • In February 2024, FUJIFILM India launched the groundbreaking ALOKA ARIETTA 850 Diagnostic Ultrasound System in India, representing a significant advancement in endoscopic technologies. The high-tech ultrasound system aimed to enhance diagnostic precision and image clarity for gastrointestinal diseases in the region.
  • In May 2023, Olympus announced the FDA clearance of the EVIS X1 endoscopy system, along with two compatible gastrointestinal endoscopes. The GIF-1100 gastrointestinal videoscope was indicated for use within the upper digestive tract, including the esophagus, stomach, and duodenum, while the CF-HQ1100DL/I colonovideoscope was indicated for use within the lower digestive tract, including the anus, rectum, sigmoid colon, colon, and ileocecal valve.

Key takeaways from the sigmoidoscopes market report study

  • Market size analysis for current sigmoidoscopes market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the sigmoidoscopes market
  • Various opportunities available for the other competitors in the sigmoidoscopes market space
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current sigmoidoscopes market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for sigmoidoscopes market growth in the coming future?

Target audience who can benefit from this sigmoidoscope market report study

  • Sigmoidoscopes product providers
  • Research organizations and consulting companies
  • Sigmoidoscopes-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in sigmoidoscopes
  • Various end-users who want to know more about the sigmoidoscopes market and the latest developments in the sigmoidoscopes market

Frequently Asked Questions for the Sigmoidoscopes Market:

1. What are sigmoidoscopes?

  • The sigmoidoscope is a medical device used for examining the rectum and sigmoid colon, which is the lower part of the large intestine. It is commonly used in diagnostic and therapeutic procedures, such as identifying abnormalities (polyps, inflammation, or cancer), monitoring inflammatory bowel disease, and performing biopsies.

2. What is the market for sigmoidoscopes?

  • The sigmoidoscopes market is estimated to grow at a CAGR of 5.57% during the forecast period from 2025 to 2032.

3. What are the drivers for the sigmoidoscopes market?

  • The sigmoidoscopes market is growing significantly due to the increasing instances of chronic conditions such colorectal cancer, inflammatory bowel diseases (IBD), diverticulitis, and polyps, growing geriatric population, rising awareness about early diagnosis of gastro-intestinal disorders, increasing shift towards minimally invasive procedures, and others that are expected to escalate the demand for sigmoidoscopes during the forecast period from 2025 to 2032.

4. Who are the key players operating in the sigmoidoscopes market?

  • Some of the key market players operating in the sigmoidoscopes market include Olympus Corporation, Baxter, Adler Instrument Company, Bioseal Inc., Rocket Medical plc., ConMed Corporation, Johnson & Johnson Services, Inc., Medtronic, Ambu A/S, SCHOLLY FIBEROPTIC GMBH, SonoScape Medical Corp., Interscope, Inc., Ovesco Endoscopy AG, and others.

5. Which region has the highest share in the sigmoidoscopes market?

  • Among all the regions, North America is expected to dominate the sigmoidoscopes market in the year 2024. This can be attributed to several factors, such as rising colorectal cancer cases, enhanced by technological advancements, regulatory approvals, and significant market presence of leading companies, continued investment in healthcare infrastructure, and innovative product developments that are expected to drive the market for sigmoidoscopes during the forecast period from 2025 to 2032.

Table of Contents

1. Sigmoidoscopes Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Sigmoidoscopes Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Sigmoidoscopes Market Key Factors Analysis

  • 5.1. Sigmoidoscopes Market Drivers
    • 5.1.1. Increasing instances of colorectal cancer and gastrointestinal disorders
    • 5.1.2. Increasing geriatric population
    • 5.1.3. Rising awareness about the early diagnosis of gastrointestinal disorders
  • 5.2. Sigmoidoscopes Market Restraints and Challenges
    • 5.2.1. Availability of alternative options
    • 5.2.2. Risk of complications and infections associated with these devices
  • 5.3. Sigmoidoscopes Market Opportunities
    • 5.3.1. Integration of sigmoidoscopes with telemedicine platforms and AI-assisted diagnostics

6. Sigmoidoscopes Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Sigmoidoscopes Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Rigid
    • 7.1.2. Flexible
  • 7.2. By Usability
    • 7.2.1. Disposable
    • 7.2.2. Reusable
  • 7.3. By End-User
    • 7.3.1. Hospitals & Clinics
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.1.2. Canada Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.1.3. Mexico Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.2. Europe
      • 7.4.2.1. France Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.2.2. Germany Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.2.3. United Kingdom Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.2.4. Italy Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.2.5. Spain Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.2.6. Rest of Europe Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.3.2. Japan Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.3.3. India Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.3.4. Australia Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.3.5. South Korea Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.3.6. Rest of Asia-Pacific Sigmoidoscopes Market Size in USD million (2022-2032)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.4.2. Africa Sigmoidoscopes Market Size in USD million (2022-2032)
      • 7.4.4.3. South America Sigmoidoscopes Market Size in USD million (2022-2032)

8. Sigmoidoscopes Market Company and Product Profiles

  • 8.1. Olympus Corporation
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Baxter
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Adler Instrument Company
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Bioseal Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Rocket Medical plc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. ConMed Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Johnson & Johnson Services, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Medtronic
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Ambu A/S
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. SCHOLLY FIBEROPTIC GMBH
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. SonoScape Medical Corp.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Interscope, Inc.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Ovesco Endoscopy AG
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Sigmoidoscopes Market in Global (2022-2032)
  • Table 3: Sigmoidoscopes Market in Global by Product Type (2022-2032)
  • Table 4: Sigmoidoscopes Market in Global by Usability (2022-2032)
  • Table 5: Sigmoidoscopes Market in Global by End-User (2022-2032)
  • Table 6: Sigmoidoscopes Market in Global by Geography (2022-2032)
  • Table 7: Sigmoidoscopes Market in North America (2022-2032)
  • Table 8: Sigmoidoscopes Market in the United States (2022-2032)
  • Table 9: Sigmoidoscopes Market in Canada (2022-2032)
  • Table 10: Sigmoidoscopes Market in Mexico (2022-2032)
  • Table 11: Sigmoidoscopes Market in Europe (2022-2032)
  • Table 12: Sigmoidoscopes Market in France (2022-2032)
  • Table 13: Sigmoidoscopes Market in Germany (2022-2032)
  • Table 14: Sigmoidoscopes Market in United Kingdom (2022-2032)
  • Table 15: Sigmoidoscopes Market in Italy (2022-2032)
  • Table 16: Sigmoidoscopes Market in Spain (2022-2032)
  • Table 17: Sigmoidoscopes Market in Rest of Europe (2022-2032)
  • Table 18: Sigmoidoscopes Market in Asia-Pacific (2022-2032)
  • Table 19: Sigmoidoscopes Market in China (2022-2032)
  • Table 20: Sigmoidoscopes Market in Japan (2022-2032)
  • Table 21: Sigmoidoscopes Market in India (2022-2032)
  • Table 22: Sigmoidoscopes Market in Australia (2022-2032)
  • Table 23: Sigmoidoscopes Market in South Korea (2022-2032)
  • Table 24: Sigmoidoscopes Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Sigmoidoscopes Market in Rest of the World (2022-2032)
  • Table 26: Sigmoidoscopes Market in the Middle East (2022-2032)
  • Table 27: Sigmoidoscopes Market in Africa (2022-2032)
  • Table 28: Sigmoidoscopes Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Sigmoidoscopes Market in Global (2022-2032)
  • Figure 3: Sigmoidoscopes Market in Global by Product Type (2022-2032)
  • Figure 4: Sigmoidoscopes Market in Global by Usability (2022-2032)
  • Figure 5: Sigmoidoscopes Market in Global by End-User (2022-2032)
  • Figure 6: Sigmoidoscopes Market in Global by Geography (2022-2032)
  • Figure 7: Sigmoidoscopes Market in North America (2022-2032)
  • Figure 8: Sigmoidoscopes Market in the United States (2022-2032)
  • Figure 9: Sigmoidoscopes Market in Canada (2022-2032)
  • Figure 10: Sigmoidoscopes Market in Mexico (2022-2032)
  • Figure 11: Sigmoidoscopes Market in Europe (2022-2032)
  • Figure 12: Sigmoidoscopes Market in France (2022-2032)
  • Figure 13: Sigmoidoscopes Market in Germany (2022-2032)
  • Figure 14: Sigmoidoscopes Market in United Kingdom (2022-2032)
  • Figure 15: Sigmoidoscopes Market in Italy (2022-2032)
  • Figure 16: Sigmoidoscopes Market in Spain (2022-2032)
  • Figure 17: Sigmoidoscopes Market in Rest of Europe (2022-2032)
  • Figure 18: Sigmoidoscopes Market in Asia-Pacific (2022-2032)
  • Figure 19: Sigmoidoscopes Market in China (2022-2032)
  • Figure 20: Sigmoidoscopes Market in Japan (2022-2032)
  • Figure 21: Sigmoidoscopes Market in India (2022-2032)
  • Figure 22: Sigmoidoscopes Market in Australia (2022-2032)
  • Figure 23: Sigmoidoscopes Market in South Korea (2022-2032)
  • Figure 24: Sigmoidoscopes Market in Rest of Asia-Pacific (2022-2032)
  • Figure 25: Sigmoidoscopes Market in Rest of the World (2022-2032)
  • Figure 26: Sigmoidoscopes Market in the Middle East (2022-2032)
  • Figure 27: Sigmoidoscopes Market in Africa (2022-2032)
  • Figure 28: Sigmoidoscopes Market in South America (2022-2032)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis